Add-on Seminars
Wednesday, February 11, 8:30 - 5:00 p.m.
Healthcare | Technology | University
Healthcare Add-on Seminar
7:30-8:30 a.m. Continental Breakfast
10:00-10:30 a.m. Coffee Break
12 noon-1:30 p.m.
Add-on Lunch - Speaker:
Christine Peterson, President, Foresight Institute
3:00-3:30 p.m. Coffee Break
Business Development - The Future:
Complexity and Opportunity
Being labeled a "deal maker" hardly begins
to describe the job of a business development
executive today. Understanding the
changing world of technology, the daily
advances in science and medicine, the
political, social, competitive and regulatory
environments in which we operate. All
while struggling to get our unique messages
out as the number of biotechnology
companies grows and the number of global
pharmaceutical companies shrinks.
These are but some of the challenges lifesciences
business development people find
themselves facing as they implement
strategies for survival and growth. The Addon
Seminar will discuss bigco's and smallco's,
vaccines and venture capitalists, the
needs of physicians and the reimbursement
systems that pay them, the beginnings of
biotech and insights into tomorrow. This is
also your opportunity to quiz pharmaceutical
company executives during the session:
"Questions I Always Wanted Somebody
Else to Ask."
Moderator
Jack Anthony, Senior Vice President,
Business and Commercial Development,
Tularik Inc.
Speakers
San Francisco: The Beginning of
the Beginning
Dave Goeddel, Chief Executive Officer,
Tularik Inc.
What Does the Physician Need Now?
Carlos Camargo, Endocrinology Clinic,
Stanford University
Vaccines: Everything that's Old is New Again
Frank Cano, Chairman and CEO, Vaxin
Big Pharma and Biotech:
A Forever Evolution?
Ken Weg, Chairman, Clearview Projects
Venture Capital Today: Still Listening?
Nick Simon, General Partner, MPM Capital
How Much Novelty Can Payers buy?
Ann Morgan Vickery, Health Practice
Director, Hogan & Hartson
Brave New World, Brave New Relationships
Glenn Rice, Vice President, SRI
No Numbers, Just Thoughts on Business
Development's Place/Role in the Coming
Years
Mark Edwards, Managing Director,
Recombinant Capital
What Does the Word Franchise Mean?
Ed Saltzman, President, Defined Health
Biogen/Idec: Is the Whole Bigger than the
Sum of the Pieces?
Mary Tanner, Senior Managing Director,
Bear Stearns
Moving from Business Development
to the CEO Spot
Ed Jennings, President and CEO, Angiogenix
Professional Forum - Questions I Always
Wanted Someone Else to Ask
Tamar Howson, Senior Vice President, BMS
Gary Cupit, Vice President, Novartis
Joe McCracken, Vice President, Genentech
Scott Foraker, Vice President, Amgen
Ray Halls, Executive Director, Merck
Lisa Riccardi, Vice President, Pfizer
Tickets may be purchased for the Welcome
Reception by individuals who attend only
the Add-on Seminars for an additional cost
of $100 per person (see registration form).
Technology Add-On Seminar
7:30-8:30 a.m. Continental Breakfast
10:00-10:30 a.m. Coffee Break
12 noon-1:30 p.m.
Add-on Lunch - Speaker:
Christine Peterson, President,
Foresight Institute
3:00-3:30 p.m. Coffee Break
Commercializing Intellectual Property:
From Concept to Product to Market
This Add-on Seminar will provide multiple
perspectives on the path to both creating
a new product and the transition from
invention to commercialization. It will cover
aspects of the "Creation Process," how
to stimulate in-house innovation, how to
analyze and determine the potential new
product value and the return on investment,
along with methods for validating
the legal aspects of licensing and branding
new IP technologies.
Presentations will be by successful inventors,
federal lab personnel and corporate
experts responsible for introducing new
technologies. Licensing professionals and
new product marketing executives will also
be included.
Moderator
Lawrence J. Udell, Executive Director,
Intellectual Property International, Ltd.
Speakers
From Invention to Product
The Creation Process - Invention Motivation
William C. Torch, M.D., M.S., Chairman, Eye-Com
Corporation, Director, Washoe Sleep
Disorders Center
Utilizing Federal Laboratories to Leverage IP
Craig Smith, Licensing Manager, Sandia
National Laboratories, U.S. Department
of Energy
Methods to Analyze New Product Potentials
Damon C. Matteo, Vice President,
Palo Alto Research Center
Increasing IP Success with New
Organizational Designs
Donna Hamlin, Ph.D., President,
Hamlin-Harkins, Ltd.
Technology to Business: Bridging the Gap
Michael Wynblatt, Ph.D., Director,
Venture Technology, Siemens Technology
From Product to Market
IP Growth Through Collaborations
Deborah Rozman, Ph.D., President,
QuantumIntech, Inc.
Validating the Intellectual Property
Todd Dickinson, Partner, Howrey, Simon,
Arnold & White
Branding New IP Technologies
Mary Lynn Coyle, Branding and Corporate
Communications Consultant
Licensing Your IP - The Intelligent
Alternative
Mark Holmes, President,
IP Venture Group, LLC
Justification for Investment - Risk Versus
Rewards
Joe Boeddeker, President, Venture Growth
Alliance, LLC
Tickets may be purchased for the Welcome
Reception by individuals who attend only
the Add-on Seminars for an additional cost
of $100 per person (see registration form).
University Add-on Seminar
7:30-8:30 a.m. Continental Breakfast
10:00-10:30 a.m. Coffee Break
12 noon-1:30 p.m.
Add-on Lunch - Speaker:
Christine Peterson, President,
Foresight Institute
3:00-3:30 p.m. Coffee Break
Don't Be Left Behind: License Early
Stage Technologies
There is a long history of innovations from
academic labs revolutionizing the marketplace,
from recombinant DNA to high speed
DSL. Business leaders in leveraging disruptive
technologies forge strong relationships
with universities and government labs. The
morning session will address how these
partnerships help these leaders achieve
goals from product and revenue opportunities
to patent peace, and showcase successes
as well as promising new technologies
for the future. The afternoon session
will feature experiences from companies
who have successfully taken multidisciplinary
technologies, from bioinformatics to
nanotechnology, to market under a variety
of licensing models.
Moderators
Katharine Ku, Director, Office of Technology
Licensing, Stanford University
Linda Chao, Licensing Associate, Office of
Technology Licensing, Stanford University
8:30-8:40 a.m.
Welcome
Katharine Ku, Director, Office of
Technology Licensing, Stanford University
8:40-10:00 a.m.
Achieving Business Goals by Partnering
with Universities and Government Labs
Milton Chang, Managing Director, iNCUBiC
Ira Blumberg, Director of Licensing,
Intel Corporation
Bryan Roberts, General Partner,
Venrock Associates
Margaret Horn, Vice President and
General Counsel, Genencor International
10:30-11:30 a.m.
Keynote Speaker: Challenges and
Opportunities in Nanotechnology
Michael Heller, Professor, Bioengineering
and Electrical and Computer Engineering
Deparments, University of California
11:30 a.m.-12 noon
Technology Showcase
1:30-3:00 p.m.
The "Quantum Dot" Story: Hear about
a Successful Nanotechnology Startup
from Academic Breakthrough to
Products on the Market for Drug
Discovery and Development
Viviana Wolinsky, Licensing Manager,
Technology Transfer Department,
Lawrence Berkeley National Laboratory
Ken Barovsky, Vice President and IP
Counsel, Quantum Dot Corporation
Moderator
Laura Mazzola, Chair, NanoBioConvergence
3:30-5:00 p.m.
Bioinformatics: Exploring the Range of
IP and Licensing Issues in the
Convergence of Biotech and
Information Technology
Fred Farina, Assistant Director, Technology
Transfer, California Institute of Technology
Charles Williams, Director, Office of
Software and Copyright Ventures, University
of Washington
Moderator
James DeGraw, Partner, Ropes & Gray
Tickets may be purchased for the Welcome
Reception by individuals who attend only
the Add-on Seminars for an additional cost
of $100 per person (see registration form).
|
